Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bluejay Diagnostics (BJDX) EPS (Weighted Average and Diluted) (2022 - 2023)

Bluejay Diagnostics' EPS (Weighted Average and Diluted) history spans 2 years, with the latest figure at -$3573.1 for Q4 2023.

  • For Q4 2023, EPS (Weighted Average and Diluted) fell 146719.67% year-over-year to -$3573.1; the TTM value through Sep 2023 reached -$75.27, down 2599.02%, while the annual FY2024 figure was -$114.19, 96.86% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2023 was -$3573.1 at Bluejay Diagnostics, down from -$2.08 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.1 in Q1 2022 and bottomed at -$3573.1 in Q4 2023.